Preferred Label : Sevelamer;

MeSH definition : A polymeric amine that binds phosphate and is used to treat HYPERPHOSPHATEMIA in patients with kidney disease.;

MeSH hyponym : GT335-012; sevelamer carbonate; RenaGel; sevelamer hydrochloride; GT335 012; GT335012; Hydrochloride, Sevelamer; Carbonate, Sevelamer;

MeSH CAS label : poly(allylamine-co-N,N'-diallyl-1,3-diamino-2-hydroxypropane);

MeSH Related Number : 845273-93-0;

Wikipedia link : https://en.wikipedia.org/wiki/Sevelamer;

Is substance : O;

UNII : 9YCX42I8IU;

Details


Main resources

You can consult :

A polymeric amine that binds phosphate and is used to treat HYPERPHOSPHATEMIA in patients with kidney disease.

https://www.has-sante.fr/jcms/p_3161193/fr/renvela
2020
false
false
false
France
sevelamer
sevelamer carbonate
chelating agents
administration, oral
insurance, health, reimbursement
treatment outcome
child
hyperphosphatemia
Renal failure-associated hyperphosphatemia (disorder)
evaluation of the transparency committee
Sevelamer

---
https://www.has-sante.fr/jcms/p_3163607
2020
France
evaluation of the transparency committee
Sevelamer
sevelamer carbonate

---
https://www.ema.europa.eu/medicines/human/EPAR/Sevelamer-carbonate-Zentiva
2015
false
United Kingdom
English
French
treatment outcome
drug evaluation
sevelamer carbonate
sevelamer carbonate
hyperphosphatemia
syndication feed
Sevelamer
Sevelamer
drug approval
drug labeling
adult
renal dialysis
peritoneal dialysis
chelating agents
chelating agents
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
administration, oral
renal insufficiency, chronic
sevelamer
package leaflet
summary of product characteristics

---
https://www.ema.europa.eu/medicines/human/EPAR/Tasermity
2015
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
sevelamer hydrochloride
sevelamer hydrochloride
sevelamer
hyperphosphatemia
chelating agents
chelating agents
adult
renal dialysis
administration, oral
tablets
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
Sevelamer
Sevelamer

---
http://www.has-sante.fr/portail/jcms/c_1647767/fr/renagel
http://www.has-sante.fr/portail/jcms/c_1647766/fr/renagel-04092013-avis-ct12662
http://www.has-sante.fr/portail/jcms/c_676986/renagel
http://www.has-sante.fr/portail/jcms/c_676949/renagel
http://www.has-sante.fr/portail/jcms/c_399758/fr/renagel-400-mg-comprime-pellicule-boite-de-360-renagel-800-mg-comprime-pellicule-boite-de-180
2013
false
France
French
Sevelamer
evaluation of the transparency committee
sevelamer hydrochloride
sevelamer
administration, oral
chelating agents
insurance, health, reimbursement
adult
peritoneal dialysis
hemodialysis
renal dialysis
hyperphosphatemia
hyperphosphatemia

---
https://www.ema.europa.eu/medicines/human/EPAR/Renvela
2012
false
United Kingdom
English
French
sevelamer carbonate
sevelamer carbonate
hyperphosphatemia
syndication feed
Sevelamer
Sevelamer
drug approval
drug labeling
adult
renal dialysis
peritoneal dialysis
chelating agents
chelating agents
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
administration, oral
renal insufficiency, chronic
sevelamer
package leaflet
summary of product characteristics

---
https://www.ema.europa.eu/medicines/human/EPAR/Renagel
2012
false
United Kingdom
English
French
syndication feed
Sevelamer
Sevelamer
sevelamer hydrochloride
sevelamer hydrochloride
chelating agents
adult
phosphates
renal dialysis
sevelamer
drug evaluation
summary of product characteristics
package leaflet
chelating agents
hyperphosphatemia
polyamines
polyamines

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2009-11/renvela_-_ct-7124.pdf
http://www.has-sante.fr/portail/jcms/c_874879/renvela
2009
false
France
French
evaluation of the transparency committee
Sevelamer
sevelamer carbonate
renal dialysis
adult
treatment outcome
administration, oral
hyperphosphatemia
renal insufficiency, chronic
chelating agents
sevelamer
insurance, health, reimbursement
polyamines

---
https://www.revmed.ch/RMS/2008/RMS-147/Place-de-la-vitamine-D-du-sevelamer-et-du-cinacalcet-dans-la-prise-en-charge-des-patients-en-insuffisance-renale
2008
true
Switzerland
French
Cinacalcet
Sevelamer
vitamins
vitamin D
renal insufficiency
hyperparathyroidism, secondary
hyperparathyroidism, secondary
vitamin D
chelating agents
journal article

---
https://www.cadth.ca/sites/default/files/pdf/HTA_349_sevelamer_tr_fr.pdf
https://www.cadth.ca/sites/default/files/pdf/HTA_349_sevelamer_appendices_fr.pdf
https://www.cadth.ca/fr/le-sevelamer-dans-linsuffisance-renale-terminale-etude-methodique-et-evaluation-economique
2006
true
Canada
French
Sevelamer
chelating agents
renal insufficiency
hyperphosphatemia
sevelamer
drug evaluation
economic evaluation

---
Nous contacter.
04/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.